Therapeutic Drug Monitoring of Vancomycin Following Critical Care Illnesses: Peak Concentration Determination Maybe Critical
Abstract
#No Abstract#
Cunha BA. Sepsis and Septic Shock: Selection of Empiric Antimicrobial Therapy. Crit Care Clin 2008;24: 313–34.
Bone RC. Gram-Negative Sepsis: a Dilemma of Modern Medicine. Clin Microbiol Rev 1993;6(1):57-68. 1. Abe R, Oda S, Sadahiro T, et al. Gram-negative bacteremia induces greater magnitude of inflammatory response than Gram-positive bacteremia. Crit Care 2010;14(2):R27. 2. DeRyke AC, Alexandr D. Optimizing Vancomycin Dosing Through Pharmacodynamic Assessment Targeting AUC/MIC. Hospital Pharmacy 2009;44(9):751-65.
Rybak M, Lomaestro B, Rotschafer JC, et al. Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health-Syst Pharm 2009; 66(1):82-98.
Mermel LA, Allon M, Bouza E, et al. Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: IDSA Guidelines for Intravascular Catheter-Related Infection. Clin Infect Dis 2009;49(1):1-45.
Rybak MJ, Lomaestro BM, Rotschafer JC, et al. Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health- System Pharmacists, and the Society of Infectious Diseases Pharmacists: Vancomycin Therapeutic Guidelines. Clin Infect Dis 2009;49(3):325-7.
Rotschafer JC, Crossley K, Zaske DE, Mead K, Sawchuk RJ, Solem LD. Pharmacokinetics of Vancomycin: Observations in 28 Patients and Dosage Recommendations. Antimicrob Agents Chemother 1982;22(3):391-4.
Khalili H, Soltani R, Negahban S, Abdollahi A, Gholami K. Reliability of Disk Diffusion Test Results for the Antimicrobial Susceptibility Testing of Nosocomial Gram-positive Microorganisms: Is E-test Method Better? Iran J Pharm Res 2012;11(2):559-63.
Fatholahzadeh B, Hashemi F, Emaneini M, Aligholi M, Nakhjavani F, Kazemi B. Detection of Vancomycin Resistant Enterococci (VRE) Isolated from Urinary Tract infections (UTI) in Tehran, Iran. Daru 2006;14(3):141-5.
Roberts JA, Lipman J. Pharmacokinetic issues for antibiotics in the critically ill patient. Crit Care Med 2009;37(3):840-51; quiz 859.
Revilla N, Martín-Suárez A, Pérez MP, González FM, Fernández de Gatta Mdel M. Vancomycin dosing assessment in intensive care unit patients based on a population pharmacokinetic/pharmacodynamic simulation Br J Clin Pharmacol 2010; 70(2): 201-12.
Shimamoto Y, Fukuda T, Tanaka K, Komori K, Sadamitsu D. Systemic inflammatory response syndrome criteria and vancomycin dose requirement in patients with sepsis. Intensive Care Med 2013;39(7):1247-52.
Mousavi S, Levcovich B, Mojtahedzadeh M. A systematic review on pharmacokinetic changes in critically ill patients: role of extracorporeal membrane oxygenation. Daru 2011;19(5):312-21.
Najmeddin F, Ahmadi A, Mahmoudi L, et al. Administration of Higher Doses of Amikacin in Early Stages of Sepsis in Critically Ill Patients. Acta Med Iran 2014;52(9):703-9.
Hadavand N, Mojtahedzadeh M, Sadray S, et al. Pharmacokinetic Behavior of Theophylline following PEEP in Critically Ill Patients with Acute Lung Injury. Iran J Pharm Res 2004, 3: 35-40.
Panahi Y, Mojtahedzadeh M, Zekeri N, Beiraghdar F, Khajavi MR, Ahmadi A. Metformin treatment in hyperglycemic critically ill patients: another challenge on the control of adverse outcomes. Iran J Pharm Res 2011;10(4):913-9.
Hadidi E, Mojtahedzadeh M, Rouini MR, et al. The evaluation of the possible effect of positive end expiratory pressure (peep) on pharmacokinetics of phenytoin in patients with acute brain injury under mechanical ventilation. Daru 2005;13(2): 74-81.
Mahmoudi L, Mohammadpour AH, Ahmadi A, Niknam R, Mojtahedzadeh M. Influence of sepsis on higher daily dose of amikacin pharmacokinetics in critically ill patients. Eur Rev Med Pharmacol Sci 2013;17(3):285-91.
| Files | ||
| Issue | Vol 2, No 3 (Summer 2014) | |
| Section | Focus | |
| Keywords | ||
| #No Keywords# | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
